AK1820

isavuconazonium sulfate · Asahi Kasei Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK1820, covering 2021-05-14 to 2021-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis [Phase 3]